会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明授权
    • Pyrrolidine ester derivatives with oxytocin modulating activity
    • 吡咯烷酯衍生物与催产素调节活性
    • US07189754B2
    • 2007-03-13
    • US10471290
    • 2002-03-19
    • Matthias SchwarzAnna QuattropaniAlexander ScheerJerome DorbaisVincent Pomel
    • Matthias SchwarzAnna QuattropaniAlexander ScheerJerome DorbaisVincent Pomel
    • A61K31/40C07D207/00
    • C07D401/10A61K31/401C07D207/22C07D403/10
    • The present invention is related to the use of pyrrolidine esters of formula (I) for the treatment and/or prevention of premature labor, premature birth and dysmenorrhea. In particular, the present invention is related to the use of pyrrolidine esters of formula (I) to modulate, notably to antagonize the oxytocin receptor. The present invention is furthermore related to novel pyrrolidine esters. X is selected from the group consisting of CR6R7, NOR6, NNR6R7; R is selected from the group comprising or consisting of C1–C6 alkyl, C2–C6 alkenyl, C2–C6 alkynyl, saturated or unsaturated 3–8-membered cycloalkyl which may contain 1 to 3 heteroatoms selected of N, O, S, aryl, heteroaryl, C1–C6-alkyl aryl, C1–C6-alkyl heteroaryl. R1 is selected from the group comprising or consisting of C1–C6-alkyl, C2–C6-alkenyl, C2–C6-alkynyl, aryl, heteroaryl, 3–8-membered cycloalkyl, acyl, C1–C6-alkyl aryl, C1–C6-alkyl heteroaryl, said cycloalkyl or aryl or heteroaryl groups may be fused with 1–2 further cycloalkyl or aryl or heteroaryl group
    • 本发明涉及式(I)的吡咯烷酯用于治疗和/或预防早产,早产和痛经的用途。 特别地,本发明涉及式(I)的吡咯烷酯的用途,特别是拮抗催产素受体。 本发明还涉及新的吡咯烷酯。 X选自CR 6,S 6,S 6,N 6,R 6,R 6, 7 ; R选自包含C 1 -C 6 -C 6烷基,C 2 -C 6 -C 6烷基,C 2 -C 6 - 烯基,C 2 -C 6炔基,饱和或不饱和的3-8元环烷基,其可以含有1-3个选自N,O,S,芳基,杂芳基的杂原子 C 1 -C 6 - 烷基芳基,C 1 -C 6 - 烷基杂芳基,C 1 -C 6 - 烷基芳基,C 1 -C 6 - R 1选自由C 1 -C 6 - C 6 - 烷基,C 2 - (C 1 -C 6)烷基组成的组或由C 1 -C 6 - C 6 - 烯基,C 2 -C 6 - 炔基,芳基,杂芳基,3-8元环烷基,酰基,C
    • 8. 发明申请
    • PHARMACEUTICALLY ACTIVE PYRROLIDINE ESTER DERIVATIVES
    • 药用活性吡咯烷酮衍生物
    • US20070129381A1
    • 2007-06-07
    • US11620359
    • 2007-01-05
    • Matthias SchwarzAnna QuattropaniAlexander ScheerJerome DorbaisVincent Pomel
    • Matthias SchwarzAnna QuattropaniAlexander ScheerJerome DorbaisVincent Pomel
    • A61K31/506A61K31/4439A61K31/401C07D403/02
    • C07D401/10A61K31/401C07D207/22C07D403/10
    • The present invention is related to the use of pyrrolidine esters of formula (I) for the treatment and/or prevention of premature labor, premature birth and dysmenorrhea. In particular, the present invention is related to the use of pyrrolidine esters of formula (I) to modulate, notably to antagonise the oxytocin receptor. The present invention is furthermore related to novel pyrrolidine esters. X is selected from the group consisting of CR6R7, NOR6, NNR6R7; R is selected from the group comprising or consisting of C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, saturated or unsaturated 3-8-membered cycloalkyl which may contain 1 to 3 heteroatoms selected of N, O, S, aryl, heteroaryl, C1-C6-alkyl aryl, C1-C6-alkyl heteroaryl. R1 is selected from the group comprising or consisting of C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, aryl, heteroaryl, 3-8-membered cycloalkyl, acyl, C1-C6-alkyl aryl, C1-C6-alkyl heteroaryl, said cycloalkyl or aryl or heteroaryl groups may be fused with 1-2 further cycloalkyl or aryl or heteroaryl group.
    • 本发明涉及式(I)的吡咯烷酯用于治疗和/或预防早产,早产和痛经的用途。 特别地,本发明涉及式(I)的吡咯烷酯的用途,特别是拮抗催产素受体。 本发明还涉及新的吡咯烷酯。 X选自CR 6,S 6,S 6,N 6,R 6,R 6, 7 ; R选自包含C 1 -C 6 -C 6烷基,C 2 -C 6 -C 6烷基,C 2 -C 6 - 烯基,C 2 -C 6炔基,饱和或不饱和的3-8元环烷基,其可以含有1-3个选自N,O,S,芳基,杂芳基的杂原子 C 1 -C 6 - 烷基芳基,C 1 -C 6 - 烷基杂芳基,C 1 -C 6 - 烷基芳基,C 1 -C 6 - R 1选自由C 1 -C 6 - C 6 - 烷基,C 2 - (C 1 -C 6)烷基组成的组或由C 1 -C 6 - C 6 - 烯基,C 2 -C 6 - 炔基,芳基,杂芳基,3-8元环烷基,酰基,C
    • 9. 发明授权
    • Triazoles as oxytocin antagonists
    • 三唑作为催产素拮抗剂
    • US07468385B2
    • 2008-12-23
    • US10498356
    • 2002-12-19
    • Anna QuattropaniMatthias SchwarzRussell J. ThomasThomas Coulter
    • Anna QuattropaniMatthias SchwarzRussell J. ThomasThomas Coulter
    • A61K31/41C07D249/08
    • C07D403/12C07D249/10C07D249/12C07D249/14C07D405/06C07D405/12
    • The present invention relates to triazole derivatives of formula (I) notably for use as pharmaceutically active compounds, as well as pharmaceutical formulations containing such triazole derivatives. Said triazoles are useful in the treatment and/or prevention of preterm labor, premature birth, dysmenorrhea, inappropriate secretion of vasopressin, congestive heart failure, arterial hypertension, liver cirrhosis, nephrotic syndrome and ocular hypertension. In particular, the present invention is related to triazole derivatives displaying a substantial modulatory, in particular antagonistic activity, of the oxytocin and/or vasopressin receptor. More preferably, said compounds are useful in the treatment and/or prevention of disease states mediated by oxytocin and/or vasopressin. The present invention is furthermore related to novel triazole derivatives as well as to methods of their preparation.
    • 本发明涉及特别用作药物活性化合物的式(I)的三唑衍生物以及含有这种三唑衍生物的药物制剂。 所述三唑可用于治疗和/或预防早产,早产,痛经,不适当的血管加压素分泌,充血性心力衰竭,动脉高血压,肝硬化,肾病综合征和高眼压症。 特别地,本发明涉及显示催产素和/或加压素受体的显着调节,特别是拮抗活性的三唑衍生物。 更优选地,所述化合物可用于治疗和/或预防催产素和/或加压素介导的疾病状态。 本发明还涉及新的三唑衍生物及其制备方法。